A MULTICENTER PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL TO EVALUATE AZIDOTHYMIDINE (AZT) TREATMENT OF THE AIDS DEMENTIA COMPLEX AND CENTRAL NERVOUS SYSTEM (CNS) HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION: